FINWIRES · TerminalLIVE
FINWIRES

Akebono Brake Industry to Book 300 Million Yen in Extraordinary Income for Fiscal Year 2027

By

Akebono Brake Industry (TYO:7238) is expected to record an extraordinary income of 300 million yen for the fiscal year ending March 31, 2027, on a consolidated basis, according to a Tokyo bourse filing on Friday.

On a non-consolidated basis, Akebono Brake expects to log a 1 billion yen extraordinary income for the same fiscal year.

The income follows the company's decision to transfer a portion of its equity interests in its Chinese subsidiary, Akebono Corp. (Guangzhou) (ACG), to joint venture partner Fujiwa Machinery Industry, while also allowing a third-party capital increase by Kunshan Technical Automotive Centre, a member of the LIOHO Group.

As a result of the transactions, Akebono's ownership in ACG will drop from 70% to 30%, with Fujiwa holding 55% and Kunshan holding 15%, and ACG will be reclassified from a consolidated subsidiary to an equity-method affiliate.

The move is part of Akebono's restructuring of its China operations, shifting principal management responsibility to the LIOHO Group while focusing more on its disc brake pad business through Akebono Corporation (Suzhou).

The equity transfer agreement is scheduled for execution on April 27, with the transaction expected to close on June 30.

Related Articles

Asia

Netwealth's FUA Net Flows in Fiscal Q4 Likely to See Seasonal Step-up, Jarden Says

Netwealth Group's (ASX:NWL) funds under administration (FUA) net flows are likely to see a seasonal step-up in the fiscal fourth quarter, which would see the fiscal 2026 outcome tracking slightly ahead of its guidance range, Jarden said in a Thursday note.It raised its earnings-per-share forecasts by 0.1% for fiscal 2026, 1.5% for fiscal 2027, and 1.6% for fiscal 2028.Jarden also flagged the risk of higher cost growth due to the enforceable undertaking, regulatory scrutiny, and recent treasury consultations.The investment firm retained its neutral recommendation on Netwealth Group and raised the price target to AU$25.70 from AU$25.35.Netwealth Group's shares gained 1% in recent Friday trade.

ASX:NWL
Asia

CDL Hospitality REIT Issues Stapled Securities as Payment of Management Fee

CDL Hospitality REIT (SGX:J85) issued 5.5 million stapled securities to its manager, H-REIT Manager and HBT Trustee-Manager as payment of management fee for 2025, according to a Friday filing with the Singapore Exchange.Nearly 5 million stapled securities were issued to the H-REIT Manager at SG$0.8199 per security as 80% payment of its performance fee for 2025.Meanwhile, 535,179 securities were issued to HBT Trustee-Manager at SG$0.8199 per security as payment of 80% of performance fee for 2025.

SGX:J85
Asia

Syntara's Myelofibrosis Drug Candidate Shows 'Significant' Commercial Potential, Euroz Hartleys Says

Syntara's (ASX:SNT) Amsulostat drug candidate has a "unique" position in the myelofibrosis landscape and "significant" commercial potential, Euroz Hartleys said in a Thursday note.Myelofibrosis is a blood cancer characterized by scar tissue formation or fibrosis in the bone marrow.Dr Adam Craig, Syntara strategic adviser and an industry leader in myelofibrosis, noted Amsulostat's mechanism targeting fibrosis, with the potential as a disease-modifying therapy, rather than just a symptomatic treatment.Craig said that Amsulostat's safety profile differs from current therapies and is unaware of any other drug taking a similar approach.Additionally, Craig said that Amsulostat's mechanism requires time for effect, as fibrosis evolves gradually. Patient responses observed at six months are complemented by a continuing improvement over time.Euroz Hartleys reaffirmed its speculative buy recommendation and AU$0.22 price target on Syntara.Syntara shares fell 1% in afternoon trade on Friday.

ASX:SNT